H1 2024 Life Sciences Update Market Summaries

Germany: Munich

View H1 2024 Life Sciences Update

View All Markets

Market Summary

Public & Private Funding (2024 H1)

Fast Lab Stats

• The Munich investment market reached a volume of 1.45 billion euros in the first half of 2024, 21% below the past five-year-average for the same period. Investor interest has increased since 2023, as investors expect pricing to be near its low point. A stabilization in yields can be observed. • International capital sources show great interest in life sciences investments in Munich However, there is a lack of adequate product that offers value-added returns. The suburbs of Munich, such as Planegg Martinsried and Freising, are in high demand from both SMEs and international companies seeking co-operational projects on-site. • Munich is one of the leading biotechnology locations in Germany. The focus of the established life sciences companies is primarily in the pharmaceutical medical sector. More than half (55%) of total employees in the life sciences sector work in the field of biotechnology, almost doubling in the past eight years. • Munich benefits from the excellent networking between research institutes and industry. Several medium-sized biotechnology companies are spinoffs of scientific institutions. The existing research institutions, as well as the university landscape (Max Planck Institute, Helmholtz Centre, LMU and TU Munich), also promote the settlement of new companies and startups. With two established biotechnology innovation and startup centers (IZB) in Martinsried and Freising, Munich possesses attractive and modern laboratory and office space.

€ Raised (MM)

Company

Deal Type

Completed

Type

33.4K Total Life Sciences Employment 450 Life Science Companies 25 Research facilities/ institutes

Orbem

Later Stage

Oct 2023

VC

€ 30.0

Mbiomics

Early Stage

Mar 2023

VC

€ 13.0

AATec Medical

Seed Round

Jul 2023

VC

€ 2.7

Mermaid Bio

Angel (individual)

Apr 2023

VC

US$0.3

Crane Biosciences

Early Stage

Jan 2023

VC

Omegga

Early Stage

Oct 2023

VC

PreOmics

Later Stage

Jul 2023

VC

Representative Investment Sale Transactions (Q3 2022 – Q2 2024)

Address

Type

Volume (€m)

GLA (sqm)

Date Buyer

Zielstattquartier, Sendling

Office

c. 90

18,500 Q3 2023 Sonar/GIC

Lindberghstraße 25, Munich

Lab/ Office/ Production

Confidential

11,300 Q4 2023 Beos

Fraunhoferstrasse 17

Lab / Office

Confidential

4,000 Q1 2022 Pamera

Representative Life Sciences Companies

Life Sciences Labor: Annual Chemist Job Postings

1,000 1,200 1,400

Company

Type

Amgen

Biotechnology

Representative Lease Transactions (Q3 2022 – Q2 2024)

Company

Address

GLA (sqm) New/Renewal

Type

Quarter

Landlord

Aenova

Pharma

- 200 400 600 800

Tilibit Nanosystems South Horizon, Koppstrasse 4

1,600 New letting 300 New letting 3,500 New letting 3,500 New letting 1,600 New letting 650 New letting 2,000 New Letting 4.500 New letting 4,200 New letting 1,300 New Letting 1,100 New letting

Office

Q1 2023 Confidential

Pfizer

Biotechnology, Pharma

Xpedite Diagnostics Hub 8, Munich Airport Business Park

Office/labs

Q4 2022 Bain/KG Capital

Regeneron

Pettenkoferstraße 18 Gisela-Stein-Straße

Office Office Office Office Office Office Office Office Office

Q4 2022 Münchener Verein AGV Q1 2024 Patritzia Deutschland

Sanofi

Pharma

Biontech

Roche Diagnostics

Pharma

Daiichi Sankyo DE Zielstattstraße 32-48

Q3 2022 Confidential Q1 2024 Rock Capital Q1 2022 Credit Suisse Q3 2022 Confidential Q3 2022 Confidential

2019

2020

2021

2022

Plectonic Biotech

Skygate, Zeppelinstraße 1-3

AstraZeneca

Landsberger Straße 300

Bio Degree-Awarding Institutions, Metro Area • Ludwig-Maximilians-Universtiät • Technische Universität München

GNA Biosolutions

Am Haag 16

ResMed

Bodenseestraße MK 2 (3)

Mbiomics Biontech

Floriansbogen 4

Q2 2023 Unknown

Forstenrieder Straße 8-14

Q3 2022 Confidential

Contributors Benedikt Kiefer benedikt.kiefer@cushwake.com

Simon Jeschioro simon.jeschioro@cushwake.com

Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook, Federal Reserve Economic Data (FRED)

CUSHMAN & WAKEFIELD

LIFE SCIENCES UPDATE | 2024 SEPTEMBER